Sonoma Orthopedic Products® Sonoma CRx™ Sterile Clavicle Fracture Repair Implants Instructions for Use These instructions for use are intended for use with the Sonoma CRx™ clavicle fracture repair implants. Refer to the Sonoma CRx™ Surgical Technique for additional information. DEVICE DESCRIPTION The Sonoma CRx™ clavicle fracture repair implants are manufactured from stainless steel. The implants are indicated for the treatment of clavicle fractures. The implants aid in the alignment and fixation of the fractured bone, but are not intended to support the loads of the bone. The implants are inserted into the intramedullary canal of the clavicle after preparation with the Sonoma CRx™ surgical instrumentation. To secure the bone fragments, the implants require mechanical actuation to deploy fixation grippers and transition the flexible Wavibody® Technology section to rigid. A single screw is inserted through the hub into the lateral fracture segment to secure the implant. The device is implanted with the Sonoma CRx™ surgical instrumentation. Refer to the Sonoma CRx™ Surgical Technique Guide and the Sonoma CRx™ Instrumentation Instructions for Use for additional information. INDICATIONS FOR USE The Sonoma CRx™ clavicle fracture repair implants are intended to be used to repair acute, malunion, or non-union fractures of the clavicle. CONTRAINDICATIONS The Sonoma CRx™ clavicle fracture repair implants are contraindicated for patients with any of the following: Active infection (i.e. active systemic infection or any infection affecting the fractured extremity). Physiologically or psychologically inadequate patient. Inadequate skin, bone, or neurovascular status (consider soft tissue status). Irreparable tendon system. Patients with high level of activity, who are not willing to modify activity level, if needed, to comply with post-operative rehabilitation. Skeletal immaturity- only if the surgical technique would affect the development of the bone after placement of the fixation implant. LB-0820, Rev E -1- Patients with poor prognosis for healing, e.g. patients with decubitus ulcer, severe protein deficiency and/or malnutrition. Patients with uncontrolled diabetes or high blood pressure. WARNINGS/ PRECAUTIONS The use of metallic surgical implants has given the surgeon a means of bone fixation and helps generally in the management of fracture and reconstructive surgery. However, these implants are intended only to assist healing and not intended to replace normal body structures. Metallic bone fixation devices are internal splints and aid alignment of the fracture while normal healing occurs. The size and shape of bones and soft tissue place limitations on the size and strength of implants. If there is delayed union or nonunion of bone in the presence of weight bearing or load bearing, the implant could eventually break due to metal fatigue. Therefore, it is important that immobilization of the fracture site be maintained until firm bony union (confirmed by clinical and radiographic examination) is established. All metallic surgical implants are subject to repeated stresses in use, even in the absence of direct weight bearing, which can result in metal fatigue. Factors such as patient’s weight, activity level, and adherence to weight bearing or load bearing instructions have an effect on the stresses to which the implant is subjected, and therefore on the life of the implant. The surgeon must be thoroughly knowledgeable not only in the medical and surgical aspects of the implant but also must be aware of the mechanical and metallurgical aspects of surgical implants. Post-operative care is extremely important. The patient must be warned that noncompliance with post-operative instructions could lead to loosening or breakage of the implant, and/or possibly migration, requiring revisional surgery. WARNINGS 1. These warnings do not include all adverse effects that could occur with surgery in general, but are important considerations particular to metallic internal fixation devices. General surgical risks should be explained to the patient prior to surgery. 2. The surgeon must be thoroughly familiar with the prosthesis, instruments, and surgical procedure prior to performing surgery. Proper surgical procedures and techniques are the responsibility of the medical professional. Each surgeon must evaluate the appropriateness of the procedure based on personal medical training and experience. Medical procedures for the optimal utilization of the implant should be determined by the physician. 3. All patients should be adequately warned of the risk associated with the use of this implant and the surgical technique. Careful review of the technique with the patient should be done prior to utilizing these prostheses. Additionally, patient’s willingness and/or ability to follow postoperative instructions may impact the surgical outcome. 4. Correct selection of the implant is extremely important. The potential for success of fracture fixation is increased by the pre-operative planning. The physician must ensure the implant is appropriate for the patient’s individual anatomy. Placement, positioning, or fixation of the prosthetic components may result in unusual stress conditions and a subsequent reduction in service life of the implant. While proper preparation can help minimize risks, the size and shape of human bones present limitations on the size and strength of implants. Metallic internal fixation devices cannot withstand activity levels and/or loads equal to those placed on normal healthy bone. LB-0820, Rev E -2- 5. 6. 7. 8. During the healing process, these devices are not designed to withstand the unsupported stress of full weight bearing or load bearing. This is a load sharing device which is designed to maintain alignment of a fracture until healing occurs. If healing is delayed, or does not occur, the implant could eventually break due to metal fatigue. Certain degenerative diseases or underlying physiological conditions such as diabetes or rheumatoid arthritis may alter the healing process, thereby increasing the risk of implant breakage. Periodic, long-term follow up is recommended to monitor the position and state of the prosthetic components, as well as the condition of the adjoining bone. The Sonoma CRx™ implants have not been evaluated for safety and compatibility in the MR (magnetic resonance) environment. They have not been tested for heating and migration in the MR environment. PRECAUTIONS 1. Surgical implants must never be reused. These are single-use devices. An explanted implant must never be reimplanted. Even though the device appears undamaged, it is neither designed nor intended for reuse. These devices must not be resterilized or reused after contact with body tissues or fluids as they have not been validated/verified for multiple uses. Reuse may increase the risk of infection. 2. Removal after fracture healing. Metallic implants can loosen, fracture, corrode, migrate, cause pain, or stress shield bone even after a fracture has healed, particularly in young, active patients. While the surgeon must make the final decision on implant removal, we recommend that whenever possible and practical for the individual patient, fixation devices may be removed once their service as an aid to healing is accomplished and within 1 year. Implant removal should be followed by adequate post-operative management to avoid reincident of the fracture. 3. Adequately instruct the patient. Post-operative care and the patient’s ability and willingness to follow doctor’s instructions are two of the most important aspects of successful fracture healing. This is particularly important should the device be used to treat an unstable fracture. The patient must be made aware of the limitations of the implant and that physical activity and full weight bearing or load bearing have been implicated in premature loosening, bending, or fracture of internal fixation devices. The patient should understand that a metallic implant is not as strong as normal, healthy bone and will fracture under normal weight bearing or load bearing in the absence of complete bone healing. Mental or physical impairment which compromises or prevents a patient’s ability to comply with necessary limitations or precautions may place that patient at a particular risk during post-operative rehabilitation. 4. Consider possibility for conservative treatment. COMPLICATIONS AND ADVERSE EFFECTS The risks and complications with this device and the implantation procedure may include: Nonunion or delayed union of the fracture which can lead to breakage of the implant, or bending, breakage or separation of the metal component(s) due to other causes; Fracture of the bone and/or fixation element leading to the need for further surgery; Loss of anatomical position with rotation, shortening, or angulation. Loosening of the prosthesis requiring repeat surgery; Loosening due to inability to stabilize at surgery; Shortening or misalignment due to compression of the fracture or bone resorption; LB-0820, Rev E -3- Pain, discomfort, or abnormal sensations due to the presence of the implant; Decrease in bone density; Necrosis of bone or bone loss possibly resulting in revision or removal; Vascular change; Infection requiring revision, possible removal of the implant, or further procedures; Bleeding requiring transfusions and/or reoperation; Local blood clots that may cause edema or clots/emboli that move to the vital organs resulting in further treatments, surgeries or possibly more serious complications such as; heart attack, stroke, coma or death; Nerve damage causing pain, numbness and/or tingling; Misalignment of the implant or bone; Limited mobility after surgery; General immobility of the shoulder; Material sensitivity or allergic reaction to materials of the implant or a foreign body; Fracture or malfunction of the implant that may or may not lead to serious injury, including reoperation; Generation of material debris; Adverse reaction to anesthesia; Migration of metal and synthetic wear debris possibly resulting in a bodily response; Dissimilar metal contact resulting in the release of corrosive by-products; Fretting resulting in the release of metallic wear debris, possibly leading to pitting and crevice corrosion; Subluxation or dislocation of the components and/or bone at the joint; Tendon rupture or tendonitis. HANDLING AND STERILIZATION This product is provided pre-sterilized by radiation for single use only. SURGICAL TECHNIQUE Refer to the Sonoma CRx™ Surgical Technique for specific implantation instructions. CAUTION DO NOT INSERT IMPLANTS WITH FIXATION GRIPPERS PARTIALLY OR FULLY DEPLOYED DO NOT FORCE OR OVERTIGHTEN THE ACTUATION DRIVER DO NOT FORCE, TWIST, OR STRIKE THE IMPLANT DURING INSERTION. DO NOT PRY AND /OR TWIST THE IMPLANT IN ORDER TO ALIGN THE FRACTURED BONES AS THE IMPLANT MAY BECOME DAMAGED AND BENT, RENDERING IT UNUSABLE IMPLANT REMOVAL Use the Sonoma CRx™ Implant Removal Kit and reference the Sonoma CRx™ Implant Removal Kit Instructions for Use for implant removal. LB-0820, Rev E -4- Caution: Federal (USA) law restricts this device to sale by or on the order of a physician. Manufacturer: Sonoma Orthopedic Products, Inc. 3589 Westwind Boulevard Santa Rosa, CA 95403 Telephone: 707-526-1335 ext. 241 www.sonomaorthopedics.com MediTech Strategic Consultants B.V. Maastrichterlaan 127-129 6291 EN Vaals The Netherlands Manufacturer Authorized European Community Representative Do Not Reuse Caution, consult accompanying documents Non-sterile Catalog Number Batch code Sterilized using gamma radiation LB-0820, Rev E -5- Use by date Contents By prescription only OR Catalog Number Description Sonoma P/N: CRx-WG2-40100-S Sonoma P/N: CRx-WG2-40110-S Sonoma P/N: CRx-WG2-40120-S Sonoma P/N: CRx-WG2-40130-S Syntec P/N: 202810 to 202840 SC27xx SC27xx-S 4mm x 100mm Sonoma CRx™ 4mm x 110mm Sonoma CRx™` 4mm x 120mm Sonoma CRx™ 4mm x 130mm Sonoma CRx™ Cortex Screw Self-Tapping Ø2.7mm x Various Lengths USA Patents 7,846,162, 7,914,533, 7,942,875, 7,909,825, 8,287,539, 8,287,541, and 8,439,917. USA and International Patents pending. ™Trademarks and ®Registered marks of Sonoma Orthopedic Products, Inc. ©2011 Sonoma Orthopedic Products, Inc. All Rights Reserved. LB-0820, Rev E -6-